Notice of Results

AstraZeneca First Quarter Results 2016

Tomorrow, Friday, 29 April 2016, AstraZeneca will release first quarter results for 2016 at 07:00 bst.

An analyst presentation of the first quarter results will take place at 12:00 bst and will be accessible by a choice of two routes:

Audio play webcast

The presentation will be available to download on the AstraZeneca Investor Relations website http://www.astrazeneca.com/investors/ before the analyst presentation begins.

Teleconference with Q&A.  Dial in numbers:

UK (freephone) 0800 376 7922

International: +44 (0) 2071 928000

Sweden (freephone): 020 792 102

USA (freephone): 866 966 1396

Conference ID: 23032512

Details of the teleconference and webcast replay facilities are available on the Investor Relations section of the AstraZeneca website http://www.astrazeneca.com/investors.

About Us

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of US $32.8 billion in 2009. For more information please visit: www.astrazeneca.com

Subscribe

Documents & Links